Kiora Pharmaceuticals (KPRX) Earnings Date, Estimates & Call Transcripts $3.42 +0.10 (+2.86%) As of 10:19 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Kiora Pharmaceuticals Earnings Summary Upcoming Earnings DateMay. 9Before Market OpensEstimatedConsensus EPS (Mar. 25) -$0.64 Actual EPS (Mar. 25) -$1.04 Missed By -$0.40 Actual Revenue (Mar. 25) $0.75MKiora Pharmaceuticals issued Q4 2024 earnings on March 25, 2025, reporting an EPS of -$1.04, which missed analysts' consensus estimates of -$0.64 by $0.40. Quarterly revenue was reported to be $0.75 million, below analysts' expectations of $0.75 million. With a trailing EPS of $1.04 and a P/E Ratio of 3.28, Kiora Pharmaceuticals' earnings are expected to decrease next year, from $1.28 to ($2.76) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Annual Report (10-K) Press Release (8-K)SEC FilingKPRX Upcoming EarningsKiora Pharmaceuticals' Q1 2025 earnings is scheduled for Friday, May 9, 2025Powered by Get Kiora Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Kiora Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataKPRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.KPRX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Kiora Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251$0.67$0.67$0.67Q2 20251-$0.66-$0.66-$0.66Q3 20251-$0.67-$0.67-$0.67Q4 20251-$0.67-$0.67-$0.67 Kiora Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/9/2025(Estimated)--------3/25/2025Q4 2024-$0.64-$1.04 -$0.40-$1.04$0.75M$0.75M11/8/2024Q3 2024-$0.90-$0.81+$0.09-$0.81--8/9/2024--$0.95-$0.53+$0.42-$0.53-$0.02M5/10/2024Q1 2024$5.58$3.42 -$2.16$0.38$16.00M$16.00M11/9/2023Q3 2023-$2.70-$8.01 -$5.31-$0.89--8/8/2023Q2 2023-$4.59-$7.11 -$2.52-$0.79--5/9/2023Q1 2023-$15.75-$9.00+$6.75-$1.00-- Kiora Pharmaceuticals Earnings - Frequently Asked Questions When is Kiora Pharmaceuticals's earnings date? Kiora Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 9th, 2025 based off last year's report dates. Learn more on KPRX's earnings history. Did Kiora Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Kiora Pharmaceuticals (NASDAQ:KPRX) missed the analysts' consensus estimate of ($0.64) by $0.40 with a reported earnings per share (EPS) of ($1.04). Learn more on analysts' earnings estimate vs. KPRX's actual earnings. How can I view Kiora Pharmaceuticals's earnings report? Kiora Pharmaceuticals's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Kiora Pharmaceuticals generate each year? Kiora Pharmaceuticals (NASDAQ:KPRX) has a recorded annual revenue of $16 million. How much profit does Kiora Pharmaceuticals generate each year? Kiora Pharmaceuticals (NASDAQ:KPRX) has a recorded net income of -$12.51 million. KPRX has generated $1.04 earnings per share over the last four quarters. What is Kiora Pharmaceuticals's price-to-earnings ratio? Kiora Pharmaceuticals (NASDAQ:KPRX) has a trailing price-to-earnings ratio of 3.28 and a forward price-to-earnings ratio of 2.67. What is Kiora Pharmaceuticals's EPS forecast for next year? Kiora Pharmaceuticals's earnings are expected to decrease from $1.28 per share to ($2.76) per share in the next year. More Earnings Resources from MarketBeat Related Companies OSTX Earnings Date IRD Earnings Date RNTX Earnings Date STTK Earnings Date HOWL Earnings Date SCYX Earnings Date ELYM Earnings Date ESLA Earnings Date CELU Earnings Date LTRN Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Is Reddit Stock a Buy, Sell, or Hold After Earnings Release?Warning or Opportunity After Super Micro Computer's EarningsAmazon Earnings: 2 Reasons to Love It, 1 Reason to Be CautiousRocket Lab Braces for Q1 Earnings Amid Soaring ExpectationsMeta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2Palantir Earnings: 1 Bullish Signal and 1 Area of ConcernVisa Q2 Earnings Top Forecasts, Adds $30B Buyback Plan This page (NASDAQ:KPRX) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kiora Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kiora Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KPRX Stock Free KPRX Stock Alerts